AU5016793A - Dual functional anti-inflammatory and immunosuppressive agents - Google Patents
Dual functional anti-inflammatory and immunosuppressive agentsInfo
- Publication number
- AU5016793A AU5016793A AU50167/93A AU5016793A AU5016793A AU 5016793 A AU5016793 A AU 5016793A AU 50167/93 A AU50167/93 A AU 50167/93A AU 5016793 A AU5016793 A AU 5016793A AU 5016793 A AU5016793 A AU 5016793A
- Authority
- AU
- Australia
- Prior art keywords
- inflammatory
- immunosuppressive agents
- dual functional
- functional anti
- dual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/83—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93339592A | 1992-08-20 | 1992-08-20 | |
| US933395 | 1992-08-20 | ||
| PCT/US1993/007728 WO1994004537A2 (en) | 1992-08-20 | 1993-08-16 | Dual functional anti-inflammatory and immunosuppressive agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5016793A true AU5016793A (en) | 1994-03-15 |
Family
ID=25463868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU50167/93A Abandoned AU5016793A (en) | 1992-08-20 | 1993-08-16 | Dual functional anti-inflammatory and immunosuppressive agents |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0656004A1 (en) |
| CN (1) | CN1090284A (en) |
| AU (1) | AU5016793A (en) |
| MX (1) | MX9305063A (en) |
| WO (1) | WO1994004537A2 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5639782A (en) * | 1992-03-04 | 1997-06-17 | Center For Innovative Technology | Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
| US5463083A (en) * | 1992-07-13 | 1995-10-31 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| PT650485E (en) | 1992-07-13 | 2001-03-30 | Millennium Pharm Inc | 2,5-DIARIL-TETRA-HYDRO-THIOPHENES -FURANES AND ANALOGS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNE DISORDERS |
| US5434151A (en) * | 1992-08-24 | 1995-07-18 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
| ES2061406B1 (en) * | 1993-05-07 | 1995-06-01 | Uriach & Cia Sa J | NEW DERIVATIVES OF 2- (QUINOLINE) WITH PHARMACOLOGICAL ACTIVITY. |
| US5750565A (en) | 1995-05-25 | 1998-05-12 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| US5792776A (en) * | 1994-06-27 | 1998-08-11 | Cytomed, Inc., | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| US5703093A (en) * | 1995-05-31 | 1997-12-30 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| CN101632669B (en) | 2000-08-04 | 2011-05-18 | Dmi生物科学公司 | Method of using diketopiperazines and composition containing them |
| KR20150080004A (en) | 2003-05-15 | 2015-07-08 | 앰피오 파마슈티컬스 인코퍼레이티드 | Treatment of t-cell mediated diseases |
| WO2009146320A1 (en) | 2008-05-27 | 2009-12-03 | Dmi Life Sciences, Inc. | Therapeutic methods and compounds |
| CA2810844C (en) | 2010-09-07 | 2017-03-21 | Dmi Acquisition Corp. | Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions |
| CA2846464A1 (en) | 2011-10-10 | 2013-04-18 | Ampio Pharmaceuticals, Inc. | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
| BR112014007675A2 (en) | 2011-10-10 | 2017-04-18 | Ampio Pharmaceuticals Inc | degenerative joint disease treatment |
| EP2771007B1 (en) | 2011-10-28 | 2018-04-04 | Ampio Pharmaceuticals, Inc. | Treatment of rhinitis |
| US9808454B2 (en) | 2013-03-15 | 2017-11-07 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
| AU2015305611B2 (en) | 2014-08-18 | 2020-04-23 | Ampio Pharmaceuticals, Inc. | Treatment of joint conditions |
| WO2016209969A1 (en) | 2015-06-22 | 2016-12-29 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
| WO2023012130A1 (en) | 2021-08-02 | 2023-02-09 | F. Hoffmann-La Roche Ag | New cyclopenta-thieno-diazepine derivatives as gaba a gamma1 pam |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4757084A (en) * | 1984-02-29 | 1988-07-12 | Merck & Co., Inc. | 2,5-diaryl tetrahydrothiophenes and analogs thereof as PAF-antagonists |
| DE3502392A1 (en) * | 1985-01-25 | 1986-07-31 | Boehringer Ingelheim KG, 6507 Ingelheim | NEW THIENO-TRIAZOLO-1,4-DIAZEPINO-2-CARBONIC ACID AMIDES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS |
| PT81492B (en) * | 1985-09-17 | 1988-03-03 | Ciba Geigy Ag | METHOD FOR PREPARING NEW FLORORATED RESORCINE ETEREES |
| PL154186B1 (en) * | 1987-07-15 | 1991-07-31 | Wellcome Found | Method for manufacturing arylic derivatives of the hydroxamic acid |
| JPH0288553A (en) * | 1988-07-14 | 1990-03-28 | Wellcome Found Ltd:The | Anti-inflammatory aryl derivative |
| FR2653119B1 (en) * | 1989-10-18 | 1994-08-05 | Lipha | NOVEL ARYLOXY ALCOYL BENZENES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. |
| WO1991012253A1 (en) * | 1990-02-07 | 1991-08-22 | Pfizer Inc. | Tetralin and chroman derivatives useful in the treatment of asthma, arthritis, and related diseases |
| RO109450B1 (en) * | 1990-05-09 | 1995-02-28 | Pfizer | Derivates of imidazo (4,5-c) pyridine, preparation processes thereof, compositions which contain them thereof and treatment method |
| DE4027470A1 (en) * | 1990-08-30 | 1992-03-05 | Boehringer Ingelheim Kg | NEW HETRAZEPINOIDE AMIDE |
| ZA919797B (en) * | 1990-12-13 | 1992-10-28 | Smithkline Beecham Corp | Bicyclo-5,6-dihydro-7h-pyrrolo-1,20-imidazol-7-ols and 7-ones |
-
1993
- 1993-08-16 WO PCT/US1993/007728 patent/WO1994004537A2/en not_active Application Discontinuation
- 1993-08-16 EP EP93920131A patent/EP0656004A1/en not_active Withdrawn
- 1993-08-16 AU AU50167/93A patent/AU5016793A/en not_active Abandoned
- 1993-08-20 MX MX9305063A patent/MX9305063A/en unknown
- 1993-08-21 CN CN 93117782 patent/CN1090284A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994004537A2 (en) | 1994-03-03 |
| MX9305063A (en) | 1994-04-29 |
| WO1994004537A3 (en) | 1994-10-27 |
| EP0656004A1 (en) | 1995-06-07 |
| CN1090284A (en) | 1994-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4166393A (en) | Auto-reclosers | |
| AU5016793A (en) | Dual functional anti-inflammatory and immunosuppressive agents | |
| AU2896497A (en) | Compounds with anti-inflammatory and immunosuppressive activities | |
| AU3561193A (en) | TNF-muteins | |
| AU3991693A (en) | Pyrazinoindoles | |
| AU5131493A (en) | Improved semiconductor architecture and application therefor | |
| AU4466793A (en) | Spray can | |
| AU6120994A (en) | Anticonvulsive agents and uses thereof | |
| AU4177593A (en) | Benzophenonehydrazones | |
| AU3432493A (en) | Interferometer structure | |
| AU3042892A (en) | Rockbolt | |
| AU4156393A (en) | Heterocyclyltriazolinones | |
| AU4100593A (en) | Iminoalcohol-oxazolidine mixtures and their use | |
| AU7001496A (en) | Anti-inflammatory agent | |
| AU5802894A (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
| AU2448292A (en) | Pyrimidine derivative and weedkiller | |
| AU5063493A (en) | Fitting | |
| AU5587594A (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
| AU3562193A (en) | Morpholin- and thiomorpholin-4-ylamides | |
| AU3461693A (en) | Saddle-cloth | |
| AU4164793A (en) | Heterocyclyltriazolinones | |
| AU2720292A (en) | Hinge | |
| AU4123093A (en) | Benzodiazepines | |
| AU4632493A (en) | Weathershed | |
| AU7677194A (en) | Sulfamethoxazole-specific immunosuppressive agents |